N 6 -methyladenosine (m 6 A) is the most common and abundant messenger RNA modification, modulated by 'writers' , 'erasers' and 'readers' of this mark 1,2 . In vitro data have shown that m 6 A influences all fundamental aspects of mRNA metabolism, mainly mRNA stability, to determine stem cell fates 3,4 . However, its in vivo physiological function in mammals and adult mammalian cells is still unknown.
(Mettl3 −/− recipients) showed no signs of disease for up to 12 weeks after transfer. Mettl3 −/− recipients continued to gain weight throughout the experiment, whereas control mice that received wild-type naive T cells (Mettl3 +/+ recipient) began losing weight in the fifth week after transfer ( Fig. 1a ). Mettl3 −/− recipients exhibited no colitis upon endoscopy, displayed normal colon length, and were found to have reduced spleen and lymph node sizes compared to wild-type control mice at the eighth week after transfer (Fig. 1b, Extended Data Fig. 3a, b) . When analysed by FACS, Mettl3 −/− CD45.2 CD4 + donor T cells were nearly undetectable in recipient colons (Fig. 1d ), as well as in the spleen, but instead remained in peripheral and mesenteric lymph nodes, whereas wild-type donor T cells were found in large numbers in all lymphoid organs of the recipients (Extended Data Fig. 3c, d ). Haematoxylin and eosin staining and analysis of colons also confirmed that the Mettl3-KO T cells caused no T cell infiltration and inflammation, whereas wildtype T cells caused severe colonic inflammation and disrupted colon structure (Fig. 1c ). Remarkably, FACS analysis further revealed that the vast majority of transferred Mettl3 −/− T cells recovered from the peripheral lymph nodes still displayed their original naive T cell marker CD45RB + as long as 12 weeks after transfer into Rag2 −/− mice, whereas the transferred wild-type cells differentiated into the effector/memory T cells (CD45RB lo ) that mediated the pathology in this model ( Fig. 2a ). We next sought to investigate whether Mettl3 −/− naive T cells were capable of proliferation and could demonstrate normal survival after transfer into Rag2 −/− mice 8 . Using CellTrace labelling of the transferred naive T cells, proliferation of wild-type cells was observable beginning from week 2, whereas Mettl3-KO T cells retained a naive phonotype and proliferated slowly. Four weeks after transfer, over 90% of wildtype cells had differentiated into effector/memory cells, while most of the Mettl3-KO T cells remained naive and failed to display increased proliferation (Fig. 2b, c) . Despite starting with a similar number of cells, wild-type cells proliferated over 50 times more than Mettl3-KO cells by the second week, and over 400 times more by week four (Fig. 2d ). No differences in apoptosis were observed between Mettl3-KO and wildtype T cells (Extended Data Fig. 3e ), suggesting the differences in cell number were not due to defects in cell viability.
To establish that m 6 A directly controls T cell homeostatic expansion, we re-introduced the wild-type Mettl3 gene or m 6 A catalytic-mutant Mettl3 gene back into Mettl3-KO naive T cells, and showed that the wild-type Mettl3 gene, but not m 6 A catalytic-mutant Mettl3, could largely rescue the differentiation defects of Mettl3-KO naive T cells in vivo (Extended Data Fig. 3f, g) . Furthermore, we also generated an additional CD4-Cre conditional mouse line for Mettl14, an essential m 6 A catalytic partner for Mettl3 in the same m 6 A 'writer' complex. Mettl14-KO mice showed an identical phenotype to Mettl3-KO mice. Specifically, 4 weeks after transfer into Rag2 −/− mice, Mettl14-KO naive T cells remained in the naive state ( Fig. 2e ), the mice displayed smaller lymphoid organs, and the cells expanded less than transferred wild-type naive T cells (Extended Data Fig. 4a-d ). Taken together, our data suggest that m 6 A RNA modification is required not only for T helper cell differentiation and proliferation in vivo, but also for T cells to properly exit the naive 'progenitor' state.
Peripheral T cell pools are maintained by complex mechanisms, and naive T cell homeostasis and survival is mainly sustained by the IL-7/ STAT5 and self-peptide-MHC/TCR signalling axes 9 . It is well established that the elevated levels of IL-7 in lymphopaenic mice induce extensive homeostatic proliferation and differentiation of naive T cells after adoptive transfer 10 . We hypothesized that the IL-7 receptor and its downstream molecular pathway were compromised in Mettl3-KO cells. Consistently, we observed markedly decreased JAK1 and STAT5 phosphorylation levels in knockout naive T cells upon IL-7 stimulation ( Fig. 3a ). Moreover, basal ERK and AKT, but not NFκ B, phosphorylation was found to be elevated in knockout naive T cells, with TCR stimulation only minimally enhancing ERK and AKT signalling. These findings are consistent with the observation that Mettl3-KO naive T cells proliferate normally ex vivo after TCR stimulation, indicating that the limited proliferation found after adoptive transfer to lymphopaenic mice was driven by defects in STAT5 phosphorylation, whereas their long-term survival in these recipients was maintained by elevated basal ERK and AKT signalling. We conclude that m 6 A controls the balance of the two essential signalling pathways to control the T cell homeostasis, IL-7-mediated JAK-STAT signalling and TCR-mediated ERK/ AKT signalling, thus uncoupling T cell proliferation from cell survival.
To explore further the molecular mechanism underlying the IL-7 signalling pathway defects, we performed RNA sequencing (RNA-seq) analysis on the naive T cells isolated from Mettl3-KO mice and littermate control wild-type mice. Consistent with our biochemical observations, the JAK-STAT and TCR signalling pathways were among the top upregulated KEGG pathways (Extended Data Fig. 5a , b, Supplementary  Table 3 ). Notably, three Suppressor of cytokine signalling (SOCS) family genes (Socs1, Socs3 and Cish) were among the most significantly upregulated genes. RNA-seq results were validated by qPCR and western blot, Figure 2 | Mettl3-KO naive T cells are locked in the naive state and proliferate much more slowly than wild-type cells after transfer into Rag2 −/− mice. a, Most of the Mettl3-KO donor cells are retained in lymph nodes (LN) and are locked in naive states 12 weeks after transfer. b, The wild-type donor naive T cells start to differentiate from the second week after transfer (CD45RB lo ), whereas the Mettl3-KO donor naive T cells always stay in naive states (CD45RB hi ). c, d, The wild-type donor naive T cells are driven to proliferate rapidly from the second week, whereas the Mettl3-KO T cells proliferate slowly, with the total number of cells recovered from pLN shown in d. e, Mettl14-KO donor naive T cells recapitulate the phenotype of Mettl3-KO donor cells. At least six animals in each group were analysed, each experiment was repeated twice, and representative images are shown.
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confirming that Socs1, Socs3 and Cish were overexpressed and SOCS1 in particular showed even higher relative expression in Mettl3-KO naive T cells ( Fig. 3c, d) , whereas other important genes in IL-7 signalling pathways did not change (Extended Data Fig. 5c ). SOCS proteins are the key physiological inhibitors of JAK-STAT signalling pathways and have important roles in T cell proliferation and differentiation 11,12 . In particular, SOCS1 is a well-known negative regulator of IL-7 signalling, and SOCS3 and CISH also inhibit STAT5 phosphorylation and T cell proliferation, while promoting ERK activity by binding to RasGAP [13] [14] [15] [16] [17] . Consistently, siRNA-mediated Socs1 knockdown partially rescued the in vivo differentiation defects of Mettl3-KO naive T cells 4 weeks after adoptive transfer into Rag2 −/− mice ( Fig. 3e , Extended Data Fig. 5d ). Altogether, overexpression of SOCS1, SOCS3 and CISH in Mettl3-KO cells probably synergistically suppresses IL-7/STAT5 signalling, and enhances ERK and AKT signalling, to inhibit naive T cell proliferation and differentiation but maintain its survival.
RNA m 6 A methylation is understood to affect RNA stability, with Mettl3 deletion resulting in loss of the m 6 A marker and in turn slower RNA decay of m 6 A targets 2-4,18 . To assess whether loss of Mettl3 resulted in decreased m 6 A methylation of SOCS family member mRNA, we performed genome-wide m 6 A methylation profiling using m 6 A-RIP-seq with wild-type CD4 + T cells, and found that Socs1 and Socs3 mRNA 3′ UTRs have highly enriched and specific m 6 A peaks ( Fig. 3f ), which is consistent with published mouse embryonic stem cell (ES cell) and mouse dendritic cell m 6 A-seq data sets 4,19 (Extended Data Fig. 5e ). We confirmed by m 6 A RNA-immunoprecipitation (RNA-IP) qPCR that Socs1, Socs3 and Cish mRNAs were m 6 A targets, and that m 6 A was lost in Mettl3-KO naive T cells ( Fig. 3g ). Next, we performed RNA decay assays and found that Socs1, Socs3 and Cish mRNA levels were all increased in Mettl3 −/− cells in comparison to wild-type cells 2 h after actinomycin-D treatment (Fig. 3h ). m 6 A has also been reported to affect RNA splicing and translation 2-4, 18 . To address these possibilities, we first performed genome-wide ribosome profiling, and found that ribosome occupancy and the calculated translation efficiency were not affected for all the related genes in Mettl3-KO cells versus wild-type cells (see Methods and Extended Data Fig. 6a-d , Supplementary Table 4 ). Next, we analysed our deep RNA-seq data, and did not find any splicing differences between Mettl3-KO and wild-type cells, suggesting that the naive T cell homeostasis defect is mainly due to m 6 A-mediated degradation, rather than splicing or translation. Taken together, these data show that loss of m 6 A modification in Mettl3-KO naive T cells leads to increased Socs1, Socs3 and Cish mRNA half-life and protein levels, thus suppressing the IL-7/STAT5 signalling pathway.
mRNA levels are tightly regulated by both transcription and degradation 20 . While the abundance of most transcripts is mainly controlled by transcription rate, it has been shown that the mRNA levels of a minority of genes (~ 17%) are significantly regulated by mRNA degradation rates, notably immediate-early inducible genes 21, 22 . Socs genes are well-known immediate-early genes induced upon IL-7 stimulation 11, 12 , thus we hypothesized that m 6 A specifically targets 'signal-dependent immediate-early genes' for degradation. Interestingly, we found that upregulated genes (including Socs1 and Socs3) in Mettl3-KO naive T cells were significantly enriched in the degradation-controlled group of genes from LPS-stimulated dendritic cells 20, 21 (chi square test, P < 0.0001, Extended Data Fig. 7a ). In addition, using the RNA decay assay we found that the mRNAs of all three Socs genes were degraded faster upon IL-7 stimulation, as early as 10 min after IL-7 stimulation, compared to control treatment in wild-type cells, whereas the accelerated mRNA degradation upon IL-7 stimulation was abrogated in Mettl3-KO naive T cells (Extended Data Fig. 7b ). To extend our observation genome-wide and estimate the rates of synthesis and degradation, we conducted a time-course s 4 Useq with IL-7 induction and found a cluster of 34 transcripts including Cish, Socs1 and Socs3 that were increased in Mettl3-KO relative to wild-type cells and show similar kinetics of induction 23 (Fig. 4a, b ; see also Methods, Extended Data Fig. 8a -c, Supplementary Table 5 ). This analysis also confirmed that the estimated degradation rates were lower in Mettl3-KO cells for Socs transcripts after IL-7 induction ( Fig. 4c, d ). We conclude that m 6 A targets a group of immediate-early inducible genes including Socs1, Socs3 and Cish for rapid mRNA degradation upon IL-7 stimulation, allowing IL-7/JAKs signalling to activate the Cish Myb Letter reSeArCH downstream target STAT5, to initiate the re-programming of naive T cells for differentiation and proliferation. T cell homeostasis is essential for maintaining the T cell pool size and forms the basis for adaptive immunity. Rather than the findings of m 6 A functions in ES cells, here we have revealed a different strategy, whereby m 6 A targets mRNAs encoding signalling proteins that control the 'gatekeeper' IL-7 signal in naive T cells, the progenitors of the adaptive immune system. Thus these targets expand the scope of m 6 A biology and enable RNA modification to affect critical dynamic signalling systems and responses to external stimuli that maintain homeostasis. Specifically, using Mettl3 and Mettl14 conditional knockout mice, our current study demonstrates a novel mechanism whereby m 6 A functions in vivo to control T cell homeostasis by inducible degradation of Socs gene family mRNA, and consequently relieves the block on IL-7 signalling and T cell proliferation (Extended Data Fig. 9 ). Our study implies that m 6 A represents an evolutionarily conserved mechanism to specifically control the degradation rates of a group of immediate-early response genes in response to various environmental stimuli. Our study illustrates not only how this important epitranscriptomic marker has an essential role in development, but also that m 6 A modifications act as a critical regulator of immune cell homeostasis and function, opening new avenues of investigation into the function of m 6 A in human health and disease. As T cells regulate the entire adaptive immune response, this has broad implications. These findings further suggest that T cell-specific delivery of m 6 A-modifying agents might be an effective treatment to alleviate various autoimmune diseases.
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Mice. Mettl3 and Mettl14 conditional knockout mice were both generated by inserting two lox sites into the first and the last introns using the CRISPR-Cas9based genome-editing system as previously described 24 (Extended Data Fig. 1a ). The gRNA and donor oligonucleotides used were as follows. For Mettl3 left side lox: 5'-AGTGCTGCCATGTGAATGAAAGG-3′ , and 5′ -AG* T* A * G The pups born were genotyped and the PCR products were sequenced to validate intact integration of the lox sequences into the right genome loci. We crossed floxed Mettl3 or Mettl14 mice with CD4-Cre mice to obtain conditional knockout mice. The CD4-Cre mice were purchased from the Jackson laboratory and have been fully backcrossed to C57BL/6 mice from the Charles River laboratories (over more than 10 generations).
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Mettl3 fl/fl without CD4-Cre, or only CD4-Cre mice had both been used as wildtype controls for Mettl3 fl/fl ; CD4-Cre mice, and we found there were no signs of differences using either one regarding our observed phenotypes. Thereafter, we only used Mettl3 fl/fl as wild-type controls for Mettl3 fl/fl ; CD4-Cre knockout mice for most of the experiments reported here. All of the knockout and wild-type mice were littermates and co-housed for any experiments described. All the mice were bred and maintained under specific-pathogen-free conditions at the animal facility of Yale University School of Medicine. Animal procedures were approved by the Institutional Animal Care and Use Committee of Yale University. Both female and male mice were used in experiments. Wherever possible, preliminary experiments were performed to determine requirements for sample size, taking into account resources available and ethical, reductionist animal use. Exclusion criteria such as inadequate staining or low cell yield due to technical problems were pre-determined. Animals were assigned randomly to experimental groups. Each cage contained animals of all the different experimental groups. Reagents and antibodies. The detailed information on all reagents and antibodies used in this study are listed in Supplementary Table 1 . CD45RB hi adoptive transfer colitis, endoscopic and histologic analysis. We performed the experiment as described 7, 25 . Briefly, pure CD4 + CD25 − CD45RB hi naive T cells were sorted from wild-type and Mettl3-KO or Mettl14-KO mice by FACS, washed twice with PBS, counted, and intravenously injected 0.5 million cells into each Rag2 −/− recipient mice. The recipient mice were monitored and weighted each week.
At week 7, colon colitis was visualized using Coloview system (Karl Storz). Briefly, colitis score was evaluated considering the consistence of stools, granularity of the mucosal surface, translucency of the colon, fibrin deposit and vascularization of the mucosa (0-3 points for each parameter). Haematoxilin and eosin staining was performed on paraffin sections of colon previously fixed in Bouin's fixative solution.
Cell proliferation and apoptosis assay. To trace T cell homeostatic proliferation in vivo, we labelled the FACS-purified CD4 + CD25 − CD45RB hi naive cells with CellTrace (ThermoFisher Scientific, C34557) before intravenous injections 8 . We then intravenously injected 0.5 million cells into each Rag2 −/− recipient mouse. We analysed the mice at 1 week, 2 weeks, 4 weeks and 10 weeks after injection by FACS using the naive T cell marker CD45RB for differentiation, and CellTrace violet for proliferation.
For apoptosis assay, we stained the in vitro cultured cells or cells from mice with annexin V and 7-AAD and analysed by FACS, in which double-negative cells are viable cells, whereas annexin V + or double-positive cells are apoptotic cells.
T cell ex vivo differentiation. We FACS sorted CD4 + C62L + CD44 lo cells with FACSAria II Cell Sorter (BD Biosciences) and activated them with plate-bound monoclonal antibodies to CD3 (10 μ g ml −1 , 145-2C11) and CD28 (1-2 μ g ml −1 , PV-1) in the presence of mouse recombinant cytokines and blocking antibodies. Specifically, T H 1 direction with IL-12 (10 ng ml −1 ) and antibody to IL-4 (11B11, 10 μ g ml −1 ); T H 2 direction with IL-4 (10 ng ml −1 ) and antibody to IFN-γ (XMG1.2, 10 μ g ml −1 ); T H 17 with IL-6 (20 ng ml −1 ), IL-23 (20 ng ml −1 ), and antibodies to IFN-γ (XMG1.2, 10 μ g ml −1 ) and IL-4 (11B11, 10 μ g ml −1 ); iT reg with TGF-β (2 ng ml −1 ), IL-2 (50 U ml −1 ), IL-23 (20 ng ml −1 ), and antibodies to IFN-γ (XMG1.2, 10 μ g ml −1 ) and IL-4 (11B11, 10 μ g ml −1 ). All cytokines were purchased from R&D. Click's (Irvine Scientific) or RPMI (SIGMA-ALDRICH) (when indicated) media were supplemented with 10% FBS, l-glutamine (2 mM), penicillin (100 U ml −1 ) and β -mercaptoethanol (40 nM). After 4 days of culture, the cells were analysed by FACS. Signalling assay. Naive T cells were isolated by FACS, counted, and 1 million cells in cell culture media were plated on each well of 48-well plate. 10 μ g of IL-7 or IL-2, or 0.2 μ l of CD3/CD28 beads (ThermoFisher Scientific, 11452D) were added into the media, mixed and incubated at 37 °C. Cells were collected before adding cytokines or antibody beads (t = 0), or 30 min (t = 30) or 60 min (t = 60) after adding the cytokines or antibody beads. The cells were lysed on ice for 30 min in RIPA buffer (ThermoFisher Scientific, 89901) with protease inhibitor cocktails (ThermoFisher Scientific, 78437) and phosphatase inhibitor cocktails (ThermoFisher Scientific, 78428). The supernatants were then used for western blot. RNA-seq. We isolated CD4 + cells using StemCell mouse CD4 + Kit (StemCell Technologies, catalogue 19852) from spleen and lymph nodes. Then pure CD4 + CD25 − CD45RB hi naive T cells were isolated by FACS sorting. We used two pairs of wild-type and knockout mice for the experiment. Total RNAs were isolated with Direct-zol RNA MicroPrep kits (Zymo Research, R2062). Yale Center for Genome Analysis (YCGA) processed the total RNA by Ribo-Zero rRNA removal kit, constructed the libraries, and subject them to standard illumine HiSeq2000 sequencing, and obtained > 40 million reads for each sample.
Raw RNA-sequencing reads were aligned to the mouse genome (mm10, GRCm38) with Tophat 26 . Gene expression levels were measured by Cufflinks and differential analysis was performed with Cuffdiff 27 . Genes were considered significantly differentially expressed if showing ≥1.5 fold change and < 0.01 P value. Gene set analysis was performed and enriched KEGG pathways were obtained through online bioinformatics tools 28 . Volcano plot and pathway plot were generated with R package 'ggplot2' 29 . We used CuffDiff and rMATS to analyse possible splicing difference events, and did not find any significant difference between Mettl3-KO and wild-type samples 30 . RT-qPCR. Total RNA was isolated from naive T cells as described in the 'RNA-seq' section, then reverse transcribed using High-Capacity cDNA Reverse Transcription Kit (ThermoFisher Scientific, 4368814). Primers used for qPCR are included in Supplementary Table 2 . All qPCRs were run on Bio-Rad CFX96 real-time system using iTaq Universal SYBR Green Supermix (Bio-Rad, #1725124). Actin-β was used as internal control to normalize the data across different samples. RNA degradation assay. Naive T cells purified by FACS sorting were plated on 96-well plates with 0.5-million cells per well. Actinomycin-D (Sigma-Aldrich, A1410) was added to a final concentration of 5 μ M, and cells were collected before or 2 h after adding actinomycin-D. Then the cells were processed as described in 'RT-qPCR' , except that the data were normalized to the t = 0 time point.
For signalling-dependent degradation assay, we first treated the naive T cells with actinomycin-D for 1 h to fully inhibit transcription, then added IL-7 (10 μ g ml −1 ) or PBS as control into each well. Cells were lysed with Trizol LS at 0, 10 min, 20 min, 30 min, or 45 min after IL-7 addition. HPLC quantification of m 6 A levels. RNA was collected with RLT buffer (Qiagen) according to the manufacturer's instructions. Two rounds of poly(A) selection were performed using PolyA purist Mag kit (Ambion). 200 ng of poly(A)-selected RNA was digested with 1 unit of nuclease P1 in 50 mM NH 4 OAc at 37 °C for 1 h, and sample was cleared on a 0.22-μ m filter. HPLC was performed on an Agilent 1290 Infinity UPLC system coupled to the Agilent 6490 Triple Quad mass spectrometer with the iFunnel. For the LC, the A solvent was water with 0.1% formic acid and the B solvent was acetonitrile with 0.1% formic acid. The MS was in positive mode, scanning for the AMP and m 6 A product ion of 136 and 150.1, respectively. Samples were run in duplicate, and m 6 A/A ratios calculated. m 6 A RNA-IP-qPCR and m 6 A RNA-IP-seq. Total RNA was isolated with TRIZOL, according to the manufacturer's instructions, and subjected to rRNA depletion with RiboMinus kit (Ambion). RNA was fragmented to ~ 100 nucleotide fragments with Ambion fragmentation reagent (40 s incubation at 94 °C). 200 ng of RNA was denatured and incubated with 20 μ l of protein A beads, previously bound to 1 μ g of anti-m 6 A polyclonal antibody (Synaptic Systems) or rabbit IgG in 1× IPP Letter reSeArCH buffer (150 mM NaCl, 10 mM TRIS-HCL and 0.1% NP-40). RNA was incubated with the antibody for 3 h at 4 °C in 1× IPP buffer. Beads were washed twice with 1× IPP buffer, twice with low salt buffer (50 mM NaCl, 10 mM TRIS-HCL and 0.1% NP-40), twice with high salt buffer (500 mM NaCl, 10 mM TRIS-HCL and 0.1% NP-40) and once with 1× IPP buffer. RNA was eluted from the beads with 50 μ l of RLT buffer, and purified with Qiagen RNeasy columns. RNA was eluted in 100 μ l of RNase free water. m 6 A enrichment was analysed on a LightCycler 480 by RT-qPCR with One-Step RT-PCR Master Mix SYBR Green (Stratagene). The PCR was carried out using a standard protocol with melting curve. The amount of target was calculated using the formula: amount of target = 2 −∆∆C t (ref. 31) . Myc peak was positive control, Myc body and Myb were negative controls for m 6 A RIP-qPCR. Two tailed t-test for unequal, unpaired data sets with heteroscedastic variation was used to compare samples.
For m 6 A RNA-IP-seq, we started with ~ 200-300 μ g of total RNA from CD4 + T cells isolated from wild-type mice using StemCell CD4 + T cell kits. Using the same protocol with scale-up reagents, the eluted IP-RNA was concentrated by ethanol precipitation, and resolved in 10 μ l DEPC water. 10 ng RNA from input and enriched IP-RNA samples were used for library preparation with the SMARTer Stranded Total RNA-seq Kit Pico Input Mammalian (Clontech) according to the manufacturer's instructions. Input and enriched samples were multiplexed with Illumia bar codes and sequenced using paired-end 2 × 75-nt cycles on an Illumina HiSeq 2500 instrument. To process m 6 A-seq data, reads were aligned using Tophat2. Macs was then used for peak calling following the protocol in ref. 32 . Samples were normalized to get pileup per million reads in each sample, using the number of reads which were left after filtering redundant tags from MACS 33 . Peaks were then visualized using IGV 34 . siRNA knockdown. Socs1 siRNA and non-targeting control siRNA were purchased from GE-Dharmacon (E-043120-00-0005), and the experiments were carried out per the manufacturer's instructions. The naive T cells with siRNA transfection were incubated at 37 °C for 3 h, then were transferred into Rag2 −/− recipient mice by intravenous injection (1 million cells per mouse). Four weeks after transfer, the cells from spleen, peripheral lymph nodes, and mesenteric lymph nodes were analysed by FACS. Representative FACS images show that the naive marker CD45RB peaks shift leftwards upon Socs1 siRNA treatment. Mettl3-KO rescue. The wild-type and catalytic dead Mettl3 genes were cloned into N103 plasmid in the Chang laboratory. To create a catalytic dead mutant Mettl3, we inserted the mutations D395A and W398A (DPPW catalytic motif of METTL3) based on published data, which show that these two residues are absolutely required for METTL3 activity [35] [36] [37] . Mettl3-KO naive T cells were isolated from Mettl3-KO mice with StemCell naive T cell purification kit, then electroporated by nucleofection by exactly following the Amaxa mouse T cell nucleofector kit manual (Lonza). 4 h after nucleofection at 37 °C, the cells were transferred into Rag2 −/− receipt mice by intravenous injection (1 million cells per mouse). Four weeks after transfer, the cells from spleen, periphery lymph nodes, and mesenteric lymph nodes were analysed by FACS for cell numbers, and naive cell marker CD45RB. The CD4 + T cells were isolated from lymph nodes using StemCell CD4 + T cell kit, and total RNA was isolated from the CD4 + T cells using Direct-zol RNA microprep columns (Zymo Research). RT-qPCR was performed using the isolated RNAs. Each group had at least five mice to ensure statistical significance. Ribosome profiling. We performed the ribosome profiling by strictly following the manual for the Illumina TruSeq Ribo Profile (Mammalian) Kit. Briefly, 50 million naive T cells were isolated from wild-type and Mettl3-KO mice, and washed and treated with 0.1 mg ml −1 cycloheximide for 1 min. After lysis, one-tenth of the cell lysate was used to isolate RNA for preparing input RNA library, the remainder was used to prepare ribosome footprints by being first digested with 60U of 10 U μ l −1 nuclease, then cleaned up by MicroSpin S-400 columns. The total RNAs and ribosome protected RNAs were then isolated with RNA Clean & Concentrator-25 kit (Zymo Research), and subjected to rRNA removal with Illumina Ribo-Zero Gold Kits. Polyacrylamide gel electrophoresis (PAGE) was used to purify the 28-nt and 30-nt long ribosome protected fragments, which were ligated 3′ adapters and prepared cDNA library. The cDNA library was PAGE gel purified again for the 70-80-nt fragments, circularized, and amplified by PCR for nine cycles, and the resulting libraries were cleaned up by AMPure XP beads, purified by PAGE purification for ~ 140-160 bp fragments, and subjected to Illumina Hi-seq for 75bp paired-end sequencing.
We used the tuxedo suite (https://www.ccb.jhu.edu/software/tophat/) to align the ribosome profiling reads and determine FPKM, fold change, and the associated P value. All genes which did not have enough reads aligned to determine FPKM were discarded, and the remaining genes were plotted. To calculate translation efficiency, HTseq was used to count the number of reads in each experiment. The normalized translation efficiency was calculated by taking the log 2 of the quotient of the ribosome footprint read count divided by the mRNA-seq read count. The individual graphs were plotted using R package (https://bioconductor. org/ packages/release/bioc/html/Sushi.html). Enrichment of s4U-labelled RNA. Naive T cells were isolated from Mettl3-KO and wild-type mice with naive T cell purification kits (StemCell). The cells were counted and aliquoted at 4-million per 1 ml FACS buffer per Eppendorf tube. Each tube except t = 0 received 10 μ g ml −1 IL-7 cytokine and was incubated at 37 °C. 15 min before being spun down and lysed with Trizol, the cells were labelled with 250 μ M s 4 U. The enrichment of s 4 U-RNA was performed using MTS-biotin chemistry 23, 38 . Briefly, cells were lysed in TRIzol, extracted with chloroform once and the nucleic acids precipitated with isopropanol. DNA was removed with DNase, the proteins removed with phenol:chloroform:isoamylalcohol extraction, and RNA isolated using isopropanol precipitation. Total RNA was sheared to ~ 200 bp by adding shearing buffer (150 mM Tris-HCl, pH 8.3, 225 mM KCl, 9 mM MgCl 2 ) and heating to 94 °C for 4 min, followed by quenching on ice with EDTA. Sheared RNA was purified using a modified protocol with the RNeasy Mini Kit (Qiagen). To biotinylate the s4U-RNA, 20 μ g sheared RNA was incubated with 2 μ g MTS-biotin in biotinylation buffer for 30 min. Excess biotin was removed via chloroform extraction using Phase-Lock Gel Tubes. RNA was precipitated with a 1:10 volume of 3 M NaOAc and an equal volume of isopropanol and centrifuged at 20,000g for 20 min. The pellet was washed with an equal volume of 75% ethanol. Purified RNA was dissolved in 50 μ l RNase-free water. Biotinylated RNA was separated from non-labelled RNA using glycogen-blocked Dynabeads Streptavidin C1 Beads (Invitrogen). Beads (10 μ l) were added to each sample and incubated for 15 min at room temperature, then washed three times with high salt wash buffer (100 μ l each, 100 mM Tris-HCl (pH 7.4), 10 mM EDTA, 1 M NaCl, and 0.1% Tween-20). In order to improve the stringency of the washes, an additional three washes with buffer TE (10 mM Tris pH 7.4, 1 mM EDTA) at 55 °C were added to the protocol. s 4 U-RNA was eluted from Dynabeads with 25 μ l freshly prepared elution buffer (10 mM DTT, 100 mM NaCl, 10 mM Tris pH 7.4, 1 mM EDTA, 10 pg μ l Schizosaccharomyces pombe total RNA (a gift from J. Berro)) and incubated for 15 min, followed by a second elution with an additional 25 μ l elution buffer. Both elutions were pooled and purified by ethanol precipitation. 1% input (200 ng sheared RNA) was also saved from each sample before enrichment, and 500 pg S. pombe total RNA was added as a normalization spike-in. s 4 U-seq library preparation and sequencing. 10ng RNA from input and enriched RNA samples was used for library preparation with the SMARTer Stranded Total RNA-seq Kit Pico Input Mammalian (Clontech) according to the manufacturer's instructions. Input and enriched samples were multiplexed with Illumina bar codes and sequenced using single-end 1 × 75-nt cycles on an Illumina HiSeq instrument. Mapping and quantification of s 4 U-seq libraries. Sequencing reads were aligned using STAR (version 2.4.2a; Dobin 2013) to a joint index of the M. musculus and S. pombe genomes (mm10 and sp2) and transcriptomes (UCSC and Ensembl Fungi v22) 39, 40 . Alignments and analysis were performed on the Yale High Performance Computing clusters. Following alignment, HTSeq-count (version 0.6.1p1) was used to quantify annotated M. musculus and S. pombe transcripts for total RNA (-t gene) and mRNA (-t exon) 41 . Tracks normalized using the S. pombe reads were uploaded to the UCSC genome browser. The scale was normalized using exogenous S. pombe RNA added before library preparation.
Transcript abundance, synthesis and degradation rates were estimated using the INSPEcT package in R 42 . Spearman correlation between samples were visualized using the corrplot package. Transcripts with significant time-dependent changes were determined and clustered using the maSigPro package in R and heatmaps were made using the pheatmap package 43 . Statistical analysis. The sample size chosen for our animal experiments in this study was estimated based on our prior experience of performing similar sets of experiments. No statistical methods were used to predetermine sample size. All animal results were included and no method of randomization was applied. The experimenters were not blinded to allocation during experiments and outcome assessment. We independently repeated the data at least once, and all attempts to reproduce the results were successful. For all the bar graphs, data are expressed as mean ± s.e.m. Statistical analyses were performed using GraphPad Prism 6. Differences were analysed by Student's t-test or two-way ANOVA test using GraphPad Prism 6. P values ≤ 0.05 were considered significant (* P < 0.05; * * P < 0.001; * * * P < 0.0001); P values > 0.05; non-significant (NS). FlowJo (Treestar) was used to analyse all the flow cytometry data. The sample sizes (biological replicates), specific statistical tests used, and the main effects of our statistical analyses for each experiment were detailed in each figure legend. Data availability. The data that support the findings of this study are available from the corresponding author upon reasonable request. RNA-seq, ribosome profiling, s4U-seq, and m 6 A RIP-seq data sets have been deposited in Gene Expression Omnibus under the accession number GSE100048.
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Extended Data Figure 1 | Abnormal T cell homeostasis in generated
Mettl3 CD4-Cre conditional knockout mice. a, The two lox sites were inserted into the first and last introns by CRISPR technology. b, Protein levels of METTL3 and its associated METTL14 were analysed by western blot in the naive T cells and in in vitro differentiated T H 1, T H 2 and T H 17 cells from Mettl3-KO and wild-type mice. c, Overall levels of RNA m 6 A methylation in naive T cells from Mettl3-KO and wild-type mice (n = 3, P = 0.0032). d, Naive T cells increased in all lymphoid organs from Mettl3-KO mice compared to littermate control wild-type mice.
Cells from spleen (SPL), mesenteric lymph node (mLN), and peripheral lymph node (pLN) were analysed by FACS by staining with CD4/CD44/ CD62L. e, f, The percentage of CD4 + CD44 lo CD62 + naive T cells increased in all three lymphoid organs in Mettl3-KO mice (e) and the total number of naive T cells in mLN and pLN also increased in knockout mice (f; n = 3). g, The cell population in the thymus did not change in Mettl3-KO (n = 3). n = number of biological replicates. Repeated three times and one set of data is shown. * * P < 0.01, * * * P < 0.001. 
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Extended Data Figure 7 | Socs genes are signal-inducible degradationcontrolled genes. a, Upregulated genes in Mettl3-KO naive T cells are significantly enriched in the degradation-controlled group of genes from LPS-stimulated dendritic cells. We compared the genes that were differentially regulated by m 6 A in naive T cells to degradation-controlled genes in dendritic cells. We can assign cluster information to 5,784 genes in our sequencing data set. We looked at the clusters where fast degradation played a key role (clusters 2, 4 and 6), and tested whether the number of genes upregulated was significant with a chi square test. The P value was < 0.0001. 'Fast deg' , genes in clusters 2,5,6; 'not fast deg' , all other clusters; 'up' , genes upregulated (marked as significant and positive fold change); 'not up' , genes that did not change or were downregulated. b, Socs1, Socs3 and Cish, but not Socs2, degraded faster upon IL-7 treatment in wild-type cells, and the faster degradation with IL-7 stimulation was abrogated in Mettl3-KO naive T cells. The naive T cells isolated from both wild-type and Mettl3-KO mice were pre-treated with actinomycin-D for 1 h to fully stop transcription before IL-7 stimulation, and the residual mRNAs at different time points were normalized back to t = 0 (100%). 
Extended Data Figure 9 | Working model for m 6 A-controlled naive T cell homeostasis. a, Mettl3-KO naive T cell molecular mechanism: loss of m 6 A leads to slower Socs mRNA degradation and increased SOCS protein levels, which blocks the IL7 pathway. b, Revised T cell differentiation model: m 6 A targets Socs1, Socs3 and Cish for inducible and rapid mRNA degradation upon IL-7 stimulation, allowing IL-7-JAKs signalling to activate the downstream target STAT5, to initiate the re-programming of the naive T cells for differentiation and proliferation.
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